|
1
|
Lombardi G, Zustovich F, Nicoletto MO, et
al: Diagnosis and treatment of malignant pleural effusion: A
systematic literature review and new approaches. Am J Clin Oncol.
33:420–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung M and Kozuch P: Treatment of
malignant ascites. Curr Treat Options Oncol. 215–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pichelmayer O, Gruenberger B, Zielinski C,
et al: Bevacizumab is active in malignant effusion. Ann Oncol.
17:18532006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kitamura K, Kubota K, Ando M, et al:
Bevacizumab plus chemotherapy for advanced non-squamous
non-small-cell lung cancer with malignant pleural effusion. Cancer
Chemother Pharmacol. 71:457–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du N, Li X, Li F, Zhao H, et al:
Intrapleural combination therapy with bevacizumab and cisplatin for
non-small cell lung cancer-mediated malignant pleural effusion.
Oncol Rep. 29:2332–2340. 2013.PubMed/NCBI
|
|
6
|
Hoeben A, Landuyt B, Highley MS, et al:
Vascular endothelial growth factor and angiogenesis. Pharmacol Rev.
56:549–580. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dvorak HF: Vascular permeability
factor/vascular endothelial growth factor: A critical cytokine in
tumor angiogenesis and a potential target for diagnosis and
therapy. J Clin Oncol. 20:4368–4380. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lohela M, Saaristo A, Veikkola T, et al:
Lymphangiogenic growth factors, receptors and therapies. Thromb
Haemost. 90:167–184. 2003.PubMed/NCBI
|
|
9
|
Shen YC, Liu MQ, Wan C, et al: Diagnostic
accuracy of vascular endothelial growth factor for malignant
pleural effusion: A meta-analysis. Exp Ther Med. 3:1072–1076.
2012.PubMed/NCBI
|
|
10
|
Ishimoto O, Saijo Y, Narumi K, et al: High
level of vascular endothelial growth factor in hemorrhagic pleural
effusion of cancer. Oncology. 63:70–75. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karatolios K, Pankuweit S, Moosdorf RG, et
al: Vascular endothelial growth factor in malignant and benign
pericardial effusion. Clin Cardiol. 35:377–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim SC, Jung SI, Kim YC, et al: Vascular
endothelial growth factor in malignant and tuberculous pleural
effusions. J Korean Med Sci. 15:279–283. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hirayama N, Tabata C, Tabata R, et al:
Pleural effusion VEGF levels as a prognostic factor of malignant
pleural mesothelioma. Respir Med. 105:137–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu IL, Su WC, Yan JJ, et al: Angiogenetic
biomarkers in non-small cell lung cancer with malignant pleural
effusion: Correlations with patient survival and pleural effusion
control. Lung Cancer. 65:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Verheul HM, Hoekman K, Jorna AS, et al:
Targeting vascular endothelial growth factor blockade: Ascites and
pleural effusion formation. Oncologist. 5:45–50. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi S: Vascular endothelial growth
factor (VEGF), VEGF receptors and their inhibitors for
antiangiogenic tumor therapy. Biol Pharm Bull. 34:1785–1788. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
American Thoracic Society, . Management of
malignant pleural effusions. Am J Respir Crit Care Med.
162:1987–2001. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mäkinen T, Veikkola T, Mustjoki S, et al:
Isolated lymphatic endothelial cells transduce growth, survival and
migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J.
20:4762–4773. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sugiura T, Inoue Y, Matsuki R, et al:
VEGF-C and VEGF-D expression is correlated with lymphatic vessel
density and lymph node metastasis in oral squamous cell carcinoma:
Implications for use as a prognostic marker. Int J Oncol.
34:673–680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stacker SA, Caesar C, Baldwin ME, et al:
VEGF-D promotes the metastatic spread of tumor cells via the
lymphatics. Nat Med. 7:186–191. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ishii H, Yazawa T, Sato H, et al:
Enhancement of pleural dissemination and lymph node metastasis of
intrathoracic lung cancer cells by vascular endothelial growth
factors (VEGFs). Lung Cancer. 45:325–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma X, Yao Y, Yuan D, et al: Recombinant
human endostatin endostar suppresses angiogenesis and
lymphangiogenesis of malignant pleural effusion in mice. PLoS One.
7:e534492012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yanagawa H, Takeuchi E, Suzuki Y, et al:
Vascular endothelial growth factor in malignant pleural effusion
associated with lung cancer. Cancer Immunol Immunother. 48:396–400.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yano S, Shinohara H, Herbst RS, et al:
Production of experimental malignant pleural effusions is dependent
on invasion of the pleura and expression of vascular endothelial
growth factor/vascular permeability factor by human lung cancer
cells. Am J Pathol. 157:1893–1903. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gary Lee YC, Melkerneker D, Thompson PJ,
et al: Transforming growth factor beta induces vascular endothelial
growth factor elaboration from pleural mesothelial cells in vivo
and in vitro. Am J Respir Crit Care Med. 165:88–94. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Croghan GA, Nichols F, Cassivi S, et al:
VEGF A, C and D levels in malignant pleural effusions. J Clin
Oncol. 26 (Suppl 20):221262008.
|
|
27
|
Sack U, Hoffmann M, Zhao XJ, et al:
Vascular endothelial growth factor in pleural effusions of
different origin. Eur Respir J. 25:600–604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kraft A, Weindel K, Ochs A, et al:
Vascular endothelial growth factor in the sera and effusions of
patients with malignant and nonmalignant disease. Cancer.
85:178–187. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Strizzi L, Catalano A, Vianale G, et al:
Vascular endothelial growth factor is an autocrine growth factor in
human malignant mesothelioma. J Pathol. 193:468–475. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yeo KT, Wang HH, Nagy JA, et al: A
prospective, observational study describing the haematological
response in patients undergoing chemotherapy treated by tri-weekly
darbepoetin alpha for anaemia. Cancer Res. 53:2912–2918.
1993.PubMed/NCBI
|
